Abstract
Purpose
This study aimed to evaluate the safety and efficacy of intra-knee stromal vascular fraction (SVF) injection in patients with symptomatic knee osteoarthritis at the midterm (3-year) follow-up.
Methods
SVF injection was applied to 25 knees of 20 patients. Eighteen patients (90%) were female, and the means ± standard deviations of age was 61.9 ± 7.8 (range, 50–76) years. Patients who received conservative treatment for at least 6 months and had radiographic Kellgren–Lawrence (K–L) grades 2 and 3 varus gonarthrosis were included in the study. SVF was obtained from the umbilical region by liposuction using local anaesthesia. Patients were followed-up for 36 months. Their visual analogue scale (VAS), Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and Lysholm scores were evaluated before and at 6, 12, 24 and 36 months post-SVF injection.
Results
A statistically significant improvement (p < 0.05) was observed in VAS, WOMAC and Lysholm scores at the first 2-year follow-up compared to baseline. However, no statistically significant difference (n.s.) was observed in VAS, WOMAC and Lysholm scores at the 3-year follow-up compared with baseline.
Conclusion
Intra-articular SVF injection decreased pain and significantly improved the functional outcomes in the first 2 years in knees with grade 2–3 osteoarthritis; however, these positive effects of the injection disappeared in the 3rd year. Although short-term successful results of SVF have been reported in the literature, prospective studies are needed for medium- and long-term results.
Similar content being viewed by others
References
Anil U, Markus DH, Hurley ET, Manjunath AK, Alaia MJ, Campbell KA et al (2021) The efficacy of intra-articular injections in the treatment of knee osteoarthritis: a network meta-analysis of randomized controlled trials. Knee 32:173–182
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L (1988) Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
Boffa A, Perucca Orfei C, Sourugeon Y, Laver L, Magalon J, Sánchez M et al (2023) Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 2: bone marrow-derived cell-based injectable therapies. Knee Surg Sports Traumatol Arthrosc. https://doi.org/10.1007/s00167-023-07320-3
Bora P, Majumdar AS (2017) Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther 8(1):145
Boada-Pladellorens A, Avellanet M, Pages-Bolibar E, Veiga A (2022) Stromal vascular fraction therapy for knee osteoarthritis: a systematic review. Ther Adv Musculoskelet Dis 14:1759720X221117879
Brophy RH, Fillingham YA (2022) AAOS clinical practice guideline summary:anagement of osteoarthritis of the knee (nonarthroplasty), Third Edition. J Am Acad Orthop Surg 30(9):721–729
Busato A, De Francesco F, Biswas R, Mannucci S, Conti G, Fracasso G et al (2020) Simple and rapid non-enzymatic procedure allows the isolation of structurally preserved connective tissue micro-fragments enriched with SVF. Cells 10(1):36
Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076–1084
Cavallo C, Boffa A, de Girolamo L, Merli G, Kon E, Cattini L et al (2023) Bone marrow aspirate concentrate quality is affected by age and harvest site. Knee Surg Sports Traumatol Arthrosc 31(6):2140–2151
DeLoach LJ, Higgins MS, Caplan AB, Stiff JL (1998) The visual analogue scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 86:102–106
Dos-Anjos Vilaboa S, Navarro-Palou M, Llull R (2014) Age influence on stromal vascular fraction cell yield obtained from human lipoaspirates. Cytotherapy 16(8):1092–1097
Dragoo JL, Carlson G, McCormick F, Khan-Farooqi H, Zhu M, Zuk PA, Benhaim P (2007) Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng 13(7):1615–1621
Garza JR, Campbell RE, Tjoumakaris FP, Freedman KB, Miller LS, Santa Maria D, Tucker BS (2020) Clinical efficacy of intra-articular mesenchymal stromal cells for the treatment of knee osteoarthritis: a double-blinded prospective randomized controlled clinical trial. Am J Sports Med 48(3):588–598
Güven S, Karagianni M, Schwalbe M, Schreiner S, Farhadi J, Bula S et al (2012) Validation of an automated procedure to isolate human adipose tissuederived cells by using the Sepax(R) technology. Tissue Eng Part C Methods 18(8):575–582
Hong Z, Chen J, Zhang S, Zhao C, Bi M, Chen X, Bi Q (2019) Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop 43(5):1123–1134
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
Koh YG, Choi YJ, Kwon SK, Kim YS, Yeo JE (2015) Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 23(5):1308–1316
Lee WS, Kim HJ, Kim KI, Kim GB, Jin W (2019) Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med 8(6):504–511
Lin K, Matsubara Y, Masuda Y, Togashi K, Ohno T, Tamura T et al (2008) Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10(4):417–426
Lysholm J, Gillquist J (1982) Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med 10(3):150–154
Mehling B, Hric M, Salatkova A, Vetrak R, Santora D, Ovariova M et al (2020) A retrospective study of stromal vascular fraction cell therapy for osteoarthritis. J Clin Med Res 12(11):747–751
Perucca Orfei C, Boffa A, Sourugeon Y, Laver L, Magalon J, Sánchez M et al (2023) Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies. Knee Surg Sports Traumatol Arthrosc 31(2):641–655
Semon JA, Zhang X, Pandey AC, Alandete SM, Maness C, Zhang S et al (2013) Administration of murine stromal vascular fraction ameliorates chronic experimental autoimmune encephalomyelitis. Stem Cells Transl Med 2(10):789–796
Victor S (2014) Isolation of stromal vascular fraction from adipose tissue obtained from postmortem source using ultrasonic cavitation WO 2014015229 A1.
Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H et al (2017) Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A 114(35):9332–9336
Yang WT, Ke CY, Yeh KT, Huang SG, Lin ZY, Wu WT, Lee RP (2022) Stromal-vascular fraction and adipose-derived stem cell therapies improve cartilage regeneration in osteoarthritis-induced rats. Sci Rep 12(1):2828
Yokota N, Yamakawa M, Shirata T, Kimura T, Kaneshima H (2017) Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee. Regen Ther 6:108–112
You D, Jang MJ, Kim BH, Song G, Lee C, Suh N et al (2015) Comparative study of autologous stromal vascular fraction and adipose-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Stem Cells Transl Med 4:351–358
Zhang S, Xu H, He B, Fan M, Xiao M, Zhang J et al (2022) Mid-term prognosis of the stromal vascular fraction for knee osteoarthritis: a minimum 5-year follow-up study. Stem Cell Res Ther 13(1):105
Funding
There is no funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Çimen, O., Irgıt, K.S., Bekmezci, T. et al. Midterm results of intra-articular stromal vascular fraction injection for the treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 31, 5012–5017 (2023). https://doi.org/10.1007/s00167-023-07555-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-023-07555-0